PACB Pacific Biosciences of California, Inc.

PACB Pacific Biosciences of California, Inc.

Healthcare · Medical Devices

Desk view

Watchinglow conviction
Basis Logged decision
Updated

Market read

POC $1.32 · VWAP $1.82 · -4.8% vs 12m avg buyer

pullback vol: expandingchurn: quiet as of

Insiders quiet 0 buy / 0 sell · Form 4, 90d

Coverage

2 watchlists

PACB Price Structure

Loading chart…

Loading timeframes…

Peers

Every watchlist PACB belongs to, members best 30-day change first — PACB highlighted in place. Each pill: 30d change, 1d/7d, and a close spark over the last 30 calendar days (~21 sessions); hover for price, RSI, and the full chart.

@biotech-capital-cycle
@ibb

Next earnings PACB reports in 18 days Nov 4

Last report Aug 5

Reported the quarter ending 2026-06-30: revenue $39M, diluted EPS -$0.14, net income -$45M (SEC filing). Across the print the stock moved -18.8% (close before → first close after).

full note →

Against street estimates

How PACB's reported EPS compared with analyst consensus. Street estimates are single-source vendor consensus (yfinance). Actuals are vendor consensus-basis EPS (often non-GAAP); edgarEps is GAAP diluted from filings — disputed flags large disagreement only. EPS only.

8 most recent of 10 quarters · newest report Aug 5 · projection Oct 16

Result
Aug 5 -0.13-0.14-10.4%Miss
May 7 -0.13-0.12+8.7%Beat
Feb 12 -0.13-0.12+10.8%Beat
Nov 5 '25 -0.14-0.12+15.1%Beat
Aug 7 '25 -0.17-0.13+21.5%Beat
May 8 '25 -0.19-0.15 GAAP ≠ +20.5%Beat
Feb 13 '25 -0.17-0.20-15.5%Miss
Nov 7 '24 -0.21-0.17+20.1%Beat

Recent news

Headlines about PACB from the desk's news pull — links go to the publisher. Not a desk read: the market read above is the desk's own.

pulled today · Oct 17

“On or before” marks an article that arrived without a publish date — the date shown is when the desk pulled it, so the article is at least that old.